SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-043051
Filing Date
2017-02-14
Accepted
2017-02-14 14:57:02
Documents
1
Group Members
BIOTECH TARGET N.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d287575dsc13ga.htm SC 13G/A 47078
  Complete submission text file 0001193125-17-043051.txt   48736
Mailing Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200
Business Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Subject) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88806 | Film No.: 17607493
SIC: 2836 Biological Products, (No Diagnostic Substances)